SV

Sanjay Velappan

Director Director DIN 01654850
DIN 01654850 First appointment Apr 2005 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Apr 2005
Shareholding value Locked Premium profile

About Sanjay Velappan

Data last updated:

Sanjay Velappan has 21 years in corporate governance. Formerly with 1 company, such as Celogen Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 01654850
Primary Designation Director
First Appointment 13 Apr 2005
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Celogen Pharma Private Limited U24230MH2005PTC152619
Director13 Apr 20052005Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Celogen Pharma Private Limited
Premium access

Shareholding and investment profile for Sanjay Velappan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Velappan

Sanjay Velappan has 21 years in corporate governance. Formerly with 1 company, such as Celogen Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Sanjay Velappan is associated with 0 companies as a director.

Sanjay Velappan has expertise in General Business.

Sanjay Velappan has 21 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available